Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235

Published 2008 View Full Article

Authors

Keywords

Journal

CANCER RESEARCH

Volume 68, Issue 22, Pages 9221-9230

Publisher

American Association for Cancer Research (AACR)

Online

2008-11-14

DOI

10.1158/0008-5472.can-08-1740

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

CANCER RESEARCH

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find Funding. Review Successful Grants.

Ask a Question. Answer a Question.